CN103638397B - Treat pachydermic cachectic Chinese medicine preparation - Google Patents
Treat pachydermic cachectic Chinese medicine preparation Download PDFInfo
- Publication number
- CN103638397B CN103638397B CN201310608489.6A CN201310608489A CN103638397B CN 103638397 B CN103638397 B CN 103638397B CN 201310608489 A CN201310608489 A CN 201310608489A CN 103638397 B CN103638397 B CN 103638397B
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- pachydermic
- cachectic
- treat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 230000001612 cachectic effect Effects 0.000 title claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 3
- 230000000694 effects Effects 0.000 abstract description 8
- 210000000952 spleen Anatomy 0.000 abstract description 6
- 230000003213 activating effect Effects 0.000 abstract description 4
- 238000005516 engineering process Methods 0.000 abstract description 4
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 206010028665 Myxoedema Diseases 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 208000003786 myxedema Diseases 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 201000004384 Alopecia Diseases 0.000 description 4
- 208000008454 Hyperhidrosis Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 231100000360 alopecia Toxicity 0.000 description 4
- 206010016256 fatigue Diseases 0.000 description 4
- 210000004209 hair Anatomy 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000002651 drug therapy Methods 0.000 description 3
- 208000011318 facial edema Diseases 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000004709 eyebrow Anatomy 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 238000000643 oven drying Methods 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000008093 supporting effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 208000002485 Adiposis dolorosa Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010034568 Peripheral coldness Diseases 0.000 description 1
- 206010048222 Xerosis Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000009666 routine test Methods 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to field of traditional Chinese medicine technology, be specifically related to one and treat pachydermic cachectic Chinese medicine preparation, be made up of the raw material of Chinese medicine of following parts by weight: Radix Caraganae Sinicae 5 parts, Radix Morindae Officinalis 3 parts, Fructus Psoraleae 3 parts, Herba Leonuri 3 parts, Ramulus Cinnamomi 2 parts, Rhizoma Smilacis Glabrae 4 parts, Herba Solani Nigri 3 parts, Rhizoma Atractylodis 3 parts.The present invention have invigorating the spleen and benefiting QI, the capable Tianjin of activating QI effect and have that determined curative effect, cure rate are high, short treating period, the feature such as have no side effect.
Description
Technical field
The invention belongs to field of traditional Chinese medicine technology, be specifically related to one and treat pachydermic cachectic Chinese medicine preparation.
Background technology
Primary disease is multiple is born in adult female.The traditional Chinese medical science is thought: the operation of body fluid relies the promotion in gas, and the not normal or overstrain internal injury of daily life all can cause the obstructed tune of lung, spleen to lose transferring, kidney loses folding, therefore easily causes stopping in water Tianjin, can not reaching whole body, with foster skin by cloth.Clinical manifestation: facial edema due to deficiency, fear of cold, speech is slow in action, limbs fatigue, deficiency of QI with disinclination to talk, and pachylosis, without sweating, without pitting edema, alopecia, hair, eyebrow are sparse.Its pathogenesis is mainly: deficiency of spleen-QI, strong fortune mistake department.Clinically by dialectically taking invigorating the spleen and benefiting QI, the capable Tianjin of activating QI is principle for the treatment of, have received good therapeutic effect.
Summary of the invention
The object of this invention is to provide one and treat pachydermic cachectic Chinese medicine preparation, have determined curative effect, instant effect, cure rate high, have no side effect, the feature of safe ready.
The pachydermic cachectic Chinese medicine preparation for the treatment of of the present invention, is made up of the raw material of Chinese medicine of following parts by weight: Radix Caraganae Sinicae 5 parts, Radix Morindae Officinalis 3 parts, Fructus Psoraleae 3 parts, Herba Leonuri 3 parts, Ramulus Cinnamomi 2 parts, Rhizoma Smilacis Glabrae 4 parts, Herba Solani Nigri 3 parts, Rhizoma Atractylodis 3 parts.
The present invention is with Radix Caraganae Sinicae, Radix Morindae Officinalis for principal agent, and Fructus Psoraleae, Herba Leonuri are adjuvant, and Ramulus Cinnamomi, Rhizoma Smilacis Glabrae, Herba Solani Nigri, Rhizoma Atractylodis are adjuvant.
Drug action mechanism in the present invention is as follows:
Radix Caraganae Sinicae: QI invigorating, diuresis, invigorate blood circulation, pain relieving.
Radix Morindae Officinalis: reinforcing the kidney and supporting YANG, bone and muscle strengthening, wind-damp dispelling.
Fructus Psoraleae: reinforcing the kidney and supporting YANG, controlling nocturnal emission with astringent drugs reducing urination, warm spleen antidiarrheal, helping inspiration to relieve asthma.
Herba Leonuri: promoting blood flow to regulate menstruation, inducing diuresis to remove edema, heat-clearing and toxic substances removing.
Ramulus Cinnamomi: diaphoresis expelling pathogenic factors from muscles, promoting the flow of QI-blood by warming the meridian, supporing yang activating QI.
Rhizoma Smilacis Glabrae: detoxifying, removing dampness, easing joint movement.
Herba Solani Nigri: heat-clearing and toxic substances removing, eliminating stagnation, diuresis.
Rhizoma Atractylodis: the spleen strengthening and damp drying, damp eliminating.
Above all medicines cure mainly and effect is all referred to higher learning of Chinese medicine undergraduate course teaching material sixth version " Chinese materia medica ", Science and Technology of Shanghai publishing house.
The present invention can make acceptable various preparation on Chinese materia medica, preferred pill.
Preparation method: medicine-feeding is concocted qualified, weigh and assort, roll altogether for fine powder and even, cross 100 order thin sieve, with cold boiled water by general for medicated powder be piller, dry or oven drying at low temperature, pack, one bag 10 grams.
Usage and consumption: oral, once a bag, take three day, within 20 days, is a course for the treatment of.
Pachydermic cachectic symptom: facial edema due to deficiency, fear of cold, speech is slow in action, limbs fatigue, deficiency of QI with disinclination to talk, and pachylosis, without sweating, without pitting edema, alopecia, hair, eyebrow are sparse.
Outcome measure:
Recovery from illness: clinical symptoms all disappears, and the no positive sign of whole body can be looked into.
Take a turn for the better: subjective symptoms is clearly better, after fatigue, still feel weak, have palpitation, lab testing: basal metabolic rate still lowers.
Invalid: clinical symptoms without significant change, with treatment before.
Therapeutic outcome: clinical trial treatment myxedema patient 400 example, myxedema patient fully recover 368 examples after a course of therapy, and account for 92%, take a turn for the better 24 examples, accounts for 6%, and invalid 8 is routine, accounts for 2%, total effective rate 98%.Shown in treating, without any side effects to patient, three large routine tests and hepatic and renal function detect no abnormal.
Model case:
Case 1: patient Fang, female, 50 years old, long-term fear of cold, cold extremities, weak, apathetic expression, uncomfortable in chest nervous, facial edema due to deficiency, alopecia, hair are sparse etc. has a surplus for 1 year.Nearly ten days self-induction exacerbation of symptoms, in June, 2011 examines my institute, looks into: lab testing, and basal metabolism is lowered, and below-20%, cholesterolemia increases, and is diagnosed as myxedema, and after giving a course for the treatment of of Drug therapy of the present invention, symptom all disappears.Follow up a case by regular visits to and do not recur for 1 year.
Case 2: patient king so-and-so, female, 47 years old, because of weak, lassitude, pachylosis was lossless, without pitting edema, once examined as myxedema in institute of traditional Chinese medicine, and therapy of combining Chinese and Western medicine 2 months is invalid.In July, 2011 my institute, oral Drug therapy of the present invention was fully recovered after the course for the treatment of, did not recur so far.
Case 3: patient thanks so-and-so, female, 48 years old, face is sallow, expression is cold and detached, xerosis cutis, without sweating, alopecia, hair are sparse, chemically examine thyroid iodine uptake and obviously alleviate, basal metabolism is lowered, be diagnosed as myxedema, fully recover after giving a course for the treatment of of Drug therapy of the present invention, do not recur so far.
The present invention has the following advantages:
(1) Chinese herbal medicine selected by the present invention all meets Pharmacopoeia of the People's Republic of China regulation, and according to compatibility, the present invention has the effect in invigorating the spleen and benefiting QI, the capable Tianjin of activating QI.
(2) the present invention not only has good therapeutical effect to myxedema, and also has obvious therapeutic effect to Neurolipomatosis, water retention obesity.
(3) the present invention is dialectical accurately, compatibility is reasonable, instant effect, cure rate are high, taking convenience.
Detailed description of the invention
Below in conjunction with embodiment, the present invention is described further.
Embodiment 1
By qualified to Radix Caraganae Sinicae 5 parts, Radix Morindae Officinalis 3 parts, Fructus Psoraleae 3 parts, Herba Leonuri 3 parts, Ramulus Cinnamomi 2 parts, Rhizoma Smilacis Glabrae 4 parts, Herba Solani Nigri 3 parts, the Rhizoma Atractylodis 3 parts process of preparing Chinese medicine, weigh and assort, roll for fine powder and even, thin sieve of mistake 100 order altogether, with cold boiled water by general for medicated powder be piller, dry or oven drying at low temperature, pack, one bag 10 grams.
Claims (1)
1. treat a pachydermic cachectic Chinese medicine preparation, it is characterized in that being made up of the raw material of Chinese medicine of following parts by weight: Radix Caraganae Sinicae 5 parts, Radix Morindae Officinalis 3 parts, Fructus Psoraleae 3 parts, Herba Leonuri 3 parts, Ramulus Cinnamomi 2 parts, Rhizoma Smilacis Glabrae 4 parts, Herba Solani Nigri 3 parts, Rhizoma Atractylodis 3 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310608489.6A CN103638397B (en) | 2013-11-26 | 2013-11-26 | Treat pachydermic cachectic Chinese medicine preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310608489.6A CN103638397B (en) | 2013-11-26 | 2013-11-26 | Treat pachydermic cachectic Chinese medicine preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103638397A CN103638397A (en) | 2014-03-19 |
| CN103638397B true CN103638397B (en) | 2016-01-13 |
Family
ID=50243769
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310608489.6A Active CN103638397B (en) | 2013-11-26 | 2013-11-26 | Treat pachydermic cachectic Chinese medicine preparation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103638397B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105497597A (en) * | 2014-11-05 | 2016-04-20 | 张苗 | Traditional Chinese medicine for treating generalized myxedema |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1387871A (en) * | 2001-05-25 | 2003-01-01 | 张金声 | Chinese medicine shenkangwan bolus and its production process |
| CN1593639A (en) * | 2004-06-18 | 2005-03-16 | 王晓东 | Chinese medicine decoction for treating flaccidity syndrome |
-
2013
- 2013-11-26 CN CN201310608489.6A patent/CN103638397B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1387871A (en) * | 2001-05-25 | 2003-01-01 | 张金声 | Chinese medicine shenkangwan bolus and its production process |
| CN1593639A (en) * | 2004-06-18 | 2005-03-16 | 王晓东 | Chinese medicine decoction for treating flaccidity syndrome |
Non-Patent Citations (1)
| Title |
|---|
| 自拟参芪附桂汤治疗甲状腺机能减退症38例;黄建强;《湖南中医药导报》;19970830;第3卷(第04期);第23-24页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103638397A (en) | 2014-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101670076B (en) | Traditional Chinese medicine composition for treating disease of chronic nephritis and preparation method thereof | |
| CN103736083A (en) | Composition for detoxifying, beautifying and slimming | |
| CN103550687B (en) | A kind of Chinese medicine composition for the treatment of the hepatic and renal YIN deficiency | |
| CN103830523A (en) | Traditional Chinese medicine composition for treating epidemic cerebrospinal meningitis | |
| CN103110876A (en) | Traditional Chinese medicine preparation for treating heart qi deficiency type bradycardia | |
| CN103638397B (en) | Treat pachydermic cachectic Chinese medicine preparation | |
| CN102327436A (en) | Traditional Chinese medicine composition for treating edema during menstruation | |
| CN104623583A (en) | Asthenia cold abdominalgia treating drug and preparation method of asthenia cold abdominalgia treating drug oral liquid | |
| CN103845580A (en) | Traditional Chinese medicine composition for treating allergic rhinitis | |
| CN103638454B (en) | The Chinese medicine preparation for the treatment of testis in children hydrocele of tunica vaginalis | |
| CN103212039B (en) | Traditional Chinese medicine composition for treating infantile cough caused by qi deficiency | |
| CN102441047A (en) | Traditional Chinese medicine preparation for treating iron-deficiency anemia | |
| CN102935214B (en) | Traditional Chinese medicinal composition for treating uremia | |
| CN101095816A (en) | Chinese traditional medicine preparations for treating diabetic neurogenic bladder | |
| CN103768214B (en) | A kind of Chinese medicine composition for the treatment of kidney yang deficiency syndrome rhinitis | |
| CN103638246A (en) | Traditional Chinese medicine pill for treating nervous eructation | |
| CN103638259A (en) | Traditional Chinese medicine pill for treating liver stagnation type irregular menstrual period | |
| CN103638431B (en) | The Chinese medicine preparation for the treatment of muscle cramp | |
| CN103028063B (en) | Traditional Chinese medicine composition for treating nephropathy | |
| CN103520676B (en) | Traditional Chinese medicine for treating kidney-qi-deficiency type headache disease | |
| CN102836404B (en) | Chinese medicine for treating chronic nephritis by using ludwigia octovalvis | |
| CN103638245B (en) | The medicine pill for the treatment of ulcerative colitis | |
| CN103638299A (en) | Traditional Chinese medicine pill for treating ventricular premature beat | |
| CN103110732B (en) | Traditional Chinese medicine wine for treating chondromalacia patellae | |
| CN103110719B (en) | Traditional Chinese medicine wine for treating kidney deficiency and essence depletion type osteoporosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| CB03 | Change of inventor or designer information |
Inventor after: Wang Keshan Inventor after: Li Qiang Inventor after: Sun Liyan Inventor after: Ruan Mei Inventor after: Tang Wenfeng Inventor before: Song Aimin |
|
| COR | Change of bibliographic data | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20151209 Address after: 255086 Shandong city of Zibo province high tech Zone Yihe Garden District 12 Building 5 unit 1 floor West households Applicant after: SHANDONG HUALIAN MINING CO., LTD. Address before: 256100 Yiyuan people's Hospital, Zibo, Shandong, China Applicant before: Song Aimin |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20181129 Address after: 401120 No. 117 Songshi North Road, Yubei District, Chongqing Patentee after: Chongqing Hongbo Environmental Protection Engineering Co., Ltd. Address before: 255086 West Household, Unit 1, Building 12, Yihe Garden District, Zibo High-tech Zone, Shandong Province Patentee before: Zibo Kewei Intellectual Property Service Co., Ltd |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20201113 Address after: 274100 Dingtao district (Yantai) Industrial Zone, Heze City, Shandong Province (north of Luhua company) Patentee after: Heze Yulong Biotechnology Co., Ltd Address before: 401120 No. 117 Songshi North Road, Yubei District, Chongqing Patentee before: CHONGQING HONGBO ENVIRONMENTAL PROTECTION ENGINEERING Co.,Ltd. |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Traditional Chinese medicine preparation for treating mucinous edema Effective date of registration: 20211124 Granted publication date: 20160113 Pledgee: Heze rural commercial bank Limited by Share Ltd. Pledgor: Heze Yulong Biotechnology Co., Ltd Registration number: Y2021980013182 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right |